查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年鼻插管的全球市場
市場調查報告書
商品編碼
1166509

2022-2029 年鼻插管的全球市場

Global Nasal Cannula Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計2022年全球鼻插管市場規模將達到63.8761億美元，2029年將達到100.8539億美元，預測期內（2022-2029年）複合年增長率為5.84%。據說

鼻插管是一種醫療器械，可為患有呼吸系統疾病的患者提供高氣流或補充氧氣。 該設備可改善氧氣輸送並提供更好的通風。 它由一根管子組成，管子的一端有兩個尖頭，氧氣從中流過。

市場動態

由於哮喘、慢性阻塞性肺病和肺炎等呼吸系統疾病的發病率增加、技術進步和新產品的推出，推動全球鼻插管市場的主要因素是鼻插管需求的增加。

研發投資的增加和新技術的進步預計將推動市場的增長。

鼻插管市場受到最新技術的推動，同時技術進步不斷增加、老年人口不斷增加、研發投資激增、哮喘和慢性阻塞性肺病等呼吸系統疾病不斷增加，以及新興市場醫療基礎設施的改善。新產品改進推動了鼻插管市場的發展.

鼻插管用於為呼吸系統疾病患者提供補充氧氣。 由於 COVID，政府啟動了各種基金和舉措，以滿足對鼻插管等必要產品的需求。 這些資金將用於生產所有基本保健產品。 由於呼吸系統疾病的增加，這些應用的市場正在全球範圍內擴大。 此外，預計主要參與者提供的技術先進的產品也將在市場增長中發揮重要作用。

各種新產品的發布和研究正在為市場的增長做出貢獻。 例如，2022 年 5 月，急慢性呼吸護理和產品提供商 Fisher & Paykel Healthcare Corporation 宣布推出 Airvo 3 高流量系統。 該設備提供比提供 Optiflow 療法的 Airvo 2 更先進的技術。 有針對性的氧氣輸送配備了 OptiO2 閉環系統，可提供準確的氧氣濃度。 這個最先進的系統還包括一個內置電池和一個大觸摸屏界面。

與鼻插管相關的副作用預計會阻礙市場增長。

鼻插管使用後的各種副作用，如咽乾、鼻乾、眼睛刺激、胃脹、面罩不適、鼻眼外傷，有時還會流鼻血等，是阻礙鼻插管市場增長的一大因素.

長期吸氧會因肺氧中毒導致眼部損傷和肺部損傷，肺部氧中毒會因高壓升高而損害肺部和眼睛。 此外，中樞神經系統高壓的累積會導致嚴重的並發症，例如健忘症，影響多個器官。 嚴格的監管也是抑制市場增長的關鍵因素。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了積極影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於病毒導致對這些鼻插管的需求，呼吸道疾病的發病率有所增加，因此鼻插管市場因 COVID 而獲得了巨大收益。 主要製造商已經啟動了各種研究和臨床試驗。 世界各地正在發生各種舉措、產品發布、合作和合併，推動市場增長。 例如，2022 年 11 月，Hamilton Medical 宣布 HAMILTON-C3 呼吸機可以在通氣或高流量氧療之間切換。 HAMILTON-C3 提供 60 l/min 的流速。 僅應更改通氣模式和患者界面。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 增加研發投資
      • 不斷進步的技術進步
    • 約束因素
      • 與鼻插管相關的副作用
    • 商機
    • 影響分析

第5章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 高流量鼻插管
  • 低流量鼻插管

第 8 章按爪形

  • 弧形和喇叭形叉腳
  • 彎曲的叉子
  • 喇叭形爪
  • 直叉

第9章材料

  • 聚氯乙烯
  • 矽膠
  • 其他

第 10 章應用

  • 支氣管哮喘
  • 慢性阻塞性肺疾病
  • 囊性纖維化
  • 睡眠呼吸暫停綜合症
  • 肺炎
  • 心血管外科
  • 糖尿病治療
  • 其他

第 11 章最終用戶

  • 醫院
  • 門診手術中心
  • 新生兒重症監護病房
  • 家庭護理
  • 其他

第12章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第13章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第14章公司簡介

  • 史密斯醫療（ICU 醫療）
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Teleflex Inc.
  • Medline Industries Inc.
  • Hamilton Medicals
  • Neotech Products
  • Medin Medical Innovations GmbH
  • Flexicare Ltd.
  • Fairmont Medical
  • Fisher & Paykel Healthcare Limited
  • Sunset Healthcare Solutions Inc.

第15章 全球鼻插管市場-DataM

簡介目錄
Product Code: DMMD1199

Market Overview

The global nasal cannula market size was valued at US$ 6,387.61 million in 2022 and is estimated to reach US$ 10,085.39 million by 2029, growing at a CAGR of 5.84% during the forecast period (2022-2029).

The nasal cannula is a medical device that provides high airflow or supplemental oxygen to patients with respiratory disorders. This device improves oxygenation and provides better ventilation. It consists of a tube that splits into two prongs at one end from which the oxygen flows.

Market Dynamics

The major factors driving the global nasal cannula market are the rising demand for nasal cannulas owing to increasing incidences of respiratory disorders such as asthma, COPD, and pneumonia, technological advancements and novel product launches.

The increasing research and development investments and novel technological advancements are expected to drive the market's growth.

The nasal cannula market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of respiratory disorders such as asthma and COPD, and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The nasal cannula is used for providing supplemental oxygen to breathing disorder patients. Due to COVID, the government started various funds and initiatives to meet the demand for the required product, such as a nasal cannula. These funds will help in the production of all essential healthcare products. The market for these applications is increasing worldwide due to the enhanced number of respiratory disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in May 2022, Fisher & Paykel Healthcare Corporation, an acute and chronic respiratory care and products provider, announced its Airvo 3 high-flow system's release. This device provides more advanced technology than Airvo 2, which delivers Optiflow therapy. For targeted oxygen delivery, it has an OptiO2 closed-loop system that delivers an accurate oxygen level. An integrated battery and a large touchscreen interface are also included in this latest system.

Side effects associated with nasal cannulas are expected to hamper the market's growth.

Various side effects after using nasal cannulas, such as dry throat, nasal dryness, eye irritation, gastric distension, mask discomfort, nasal and eye trauma and sometimes bleeding nose, are the major factor hindering the growth of the nasal cannula market.

Long-term supplemental oxygen usage may result in eye damage or lung damage due to pulmonary oxygen toxicity, a condition in which high-pressure build-up causes damage to the lungs or eyes. It can even cause severe complications such as amnesia due to high-pressure build-up in the CNS and can affect multiple organs. Stringent regulations are also a key factor hindering the growth of the market.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The nasal cannula market has experienced huge profits due to COVID, as the incidence of respiratory disorders increased due to the virus leading to demand these nasal cannulas. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Nov 2022, Hamilton Medical announced that its HAMILTON-C3 Ventilator could be switched between ventilation or high-flow oxygen therapy. HAMILTON-C3 provides 60 liters/minute flow rate. Only the mode of ventilation and patient interface is needed to be changed.

Segment Analysis

The high-flow nasal cannula-type segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The type segment is the highest market holder in the global nasal cannula market. The global nasal cannula market is segmented based on type as a high-flow nasal cannula and low-flow nasal cannula. The high-flow nasal cannula segment is the largest market shareholder due to its inherent advantages over low-flow cannulas, increasing technological advancements and novel product launches.

The high-flow nasal cannula is a non-invasive respiratory help. This oxygen system delivers around 100% heated and humidified oxygen at approximately 60 liters per minute flow rate. The high-flow cannulas settings are independent and provide better outcomes and high confidence and control when used in supplemental oxygen delivery. High-flow nasal cannulas have various benefits, as humidified and heated oxygen decreases airway inflammation and energy expenditure.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Fisher & Paykel Healthcare Corporation Limited, an acute and chronic respiratory care products provider, announced the launch of its products Optiflow Switch and Optiflow Trace, two latest nasal high-flow interfaces specially designed for applications in anesthesia. These will expand Optiflow nasal high-flow's market opportunity within the company's respiratory segment. The optiflow Switch interface is developed for anesthesia and provides high-humidified oxygen flow. The Optiflow Trace interface is used for the sedation procedure that provides high humidified oxygen flow and samples the expired CO2.

Geographical Analysis

North America holds the largest market share in the global nasal cannula market.

North America dominates the global nasal cannula market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of applications of the nasal cannula in several respiratory diseases or surgical procedures, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the nasal cannula market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Dec 2021, Sunset Healthcare Solutions, a respiratory and medical equipment supplier, announced its partnership with Vizient Supply LLC.

Competitive Landscape

The nasal cannula market is moderately competitive with local and global companies' presence. Smith's Medical (ICU Medical), Teleflex Inc., Medline Industries Inc., Hamilton Medicals, Neotech Products, Medin Medical Innovations GmbH, Flexicare Ltd., Fairmont Medical, Fisher & Paykel Healthcare Limited, Sunset Healthcare Solutions Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in October 2022, Medline announced its multi-year vendor partnership with Hoag Memorial Hospital Presbyterian health system to provide essential medical supplies portfolio to the acute and non-acute care network.

Smith's Medical (ICU Medical).

Overview: Smith's Medical, now a part of ICU Medical, is a developer and manufacturer of innovative medical products used in vital care applications. Established in 1940 and is headquartered in Minnesota, United States.

Product Portfolio:

Portex First Breath: This nasal cannula provides O2 in low and medium concentrations, with flared or non-flared tips. It can be used for adults, neonatal, as well as pediatrics.

Key Development: In Jan 2022, ICU Medical Inc. announced its acquisition of Smith's Medical. Adding vital care products to the ICU portfolio.

The global nasal cannula market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing research and development investments
      • 4.1.1.2. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with nasal cannula
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. High Flow Nasal Cannula*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Low Flow Nasal Cannula

8. By Prong Shape

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 8.1.2. Market Attractiveness Index, By Prong Shape
  • 8.2. Curved and Flared Prongs *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Curved Prongs
  • 8.4. Flared Prongs
  • 8.5. Straight Prongs

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. PVC *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Silicone
  • 9.4. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Asthma *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. COPD
  • 10.4. Cystic Fibrosis
  • 10.5. Sleep Apnea
  • 10.6. Pneumonia
  • 10.7. Cardiovascular Surgery
  • 10.8. Diabetes Treatment
  • 10.9. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Neonatal Intensive Care Units
  • 11.5. Home Care Setting
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Products Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Smith's Medical (ICU Medical) *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Teleflex Inc.
  • 14.3. Medline Industries Inc.
  • 14.4. Hamilton Medicals
  • 14.5. Neotech Products
  • 14.6. Medin Medical Innovations GmbH
  • 14.7. Flexicare Ltd.
  • 14.8. Fairmont Medical
  • 14.9. Fisher & Paykel Healthcare Limited
  • 14.10. Sunset Healthcare Solutions Inc.

LIST NOT EXHAUSTIVE

15. Global Nasal Cannula Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Application
  • 15.3. Contact Us